How I treat rituximab refractory patients with WM

Oncotarget. 2018 Dec 7;9(96):36824-36825. doi: 10.18632/oncotarget.26411.
No abstract available

Keywords: MYD88; Waldenstrom Macroglobulinemia; ibrutinib; refractory; rituximab.

Publication types

  • Editorial